vigilneuro.com (VIGL) - Biznesning o‘zini qoplash muddati
Intellektual mulkni himoya qilish va FDA ning qat'iy tartibga soluvchi talablari Markaziy Nerv Tizimi (CNS) segmentiga yangi kiruvchilar uchun yengib bo'lmas to'siqni yaratadi. Mikrogliyani nishonga olishning innovatsion usuli Vigil Neuroscience (VIGL) kompaniyasiga tor yo'nalishlarda monopol narx belgilash imkoniyatiga ega bo'lish imkonini beradi. -4.20 ko'rsatkichi bilan taqdim etilgan ushbu narxlar tendentsiyasi vizualizatsiyasi demensiya dori vositalarining ishlab chiqilishini tezlashtirayotgan ilmiy jamg'armalar bilan hamkorlik ma'lumotlarini to'ldiradi.
Vigil Neuroscience Inc. (VIGL) kompaniyasining tahliliy kesimlari
- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Vigil Neuroscience|VIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Vigil Neuro|VIGL - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Vigil Neuroscience, Inc.|VIGL - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Vigil Neuroscience|Tezkor likvidlik koeffitsiyenti vigilneuro.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
VIGL - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Vigil Neuroscience|VIGL - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Vigil Neuro|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Vigil Neuroscience, Inc.|VIGL - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Vigil Neuroscience|VIGL - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi vigilneuro.com|VIGL - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Vigil Neuroscience
Kompaniyaning har tomonlama tahlili:vigilneuro.com VIGL
Vigil Neuroscience (VIGL) Altsgeymer kasalligi va leukoensefalopatiyalarni nishonga oluvchi dori vositalari portfelini kengaytirmoqda. Ushbu biotexnologiya kompaniyasining foyda dinamikasi ushbu koeffitsiyentning operatsion muvaffaqiyatlarga sezgirligini bevosita belgilaydi. Mazkur metrika bozor kapitalizatsiyasini sof foyda bilan solishtirish orqali investitsiyalarning qoplanish muddatini o'lchaydi, bu esa investorlarga spekulyativ qizishni aktivlarning fundamental e'tirofi bilan ajratish imkonini beradi. Kompaniyaning P/E baholashini tahlil qilish orqali investor kapitalni saqlab qolish va imkoniyatni boy berish xavfi o'rtasidagi muvozanatni topadi.
Muhim raqobatchilar
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Biznesning o‘zini qoplash muddati Regencell Bioscience Ltd|P/E multiplikatori AXSM (Axsome Therapeutics Inc)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti ACADIA Corp|Xenon Pharmaceuticals - P/E multiplikatori|Biznesning o‘zini qoplash muddati vikingtherapeutics.com VKTX|Supernus (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharma) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti DNLI|HRMY: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Biohaven Ltd. (BHVN)|amylyx.com - Narx-foyda multiplikatori|P/E multiplikatori TRVI (Trevi Therapeutics, Inc.)|Praxis Precision Medicines Inc (PRAX) - Kapitalizatsiyaning foydaga nisbati|AVXL: Narx-foyda koeffitsiyenti|CBLL - P/E multiplikatori|prothena.com (PRTA) - Narxning foydaga nisbati|Alector - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Annexon|Kapitalizatsiyaning foydaga nisbati Omeros Corp. OMER|Narxning foydaga nisbati Neurogene Corp (NGNE)|Biznesning o‘zini qoplash muddati AC Immune Inc|P/E multiplikatori VYGR (Voyager Therapeutics)|NMRA - Narx-foyda koeffitsiyenti|Scilex - P/E multiplikatori|Biznesning o‘zini qoplash muddati Tevogen Bio Holdings Inc. TVGN|ACOG: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Cognition Therapeutics Inc. (CGTX)|Narxning foydaga nisbati Inhibikase Therapeutics|Narx-foyda multiplikatori SAVA (cassavasciences.com)|P/E multiplikatori ASRT|Narx-foyda koeffitsiyenti coyatherapeutics.com COYA|P/E multiplikatori VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalizatsiyaning foydaga nisbati|ABOS: Narx-foyda koeffitsiyenti|CRVO: Narxning foydaga nisbati|ATHE: P/E multiplikatori|CLNN - Biznesning o‘zini qoplash muddati|PEPG (PepGen Inc) - P/E multiplikatori|JUNS - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Relmada Therapeutics (RLMD)|Narxning foydaga nisbati ANVS (annovisbio.com)|Narxning foydaga nisbati Grace Therapeutics GRCE|AIFF: Narx-foyda multiplikatori|ANEW Medical, Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals) - Narx-foyda koeffitsiyenti|MetaVia (MTVA) - P/E multiplikatori|Narxning foydaga nisbati NeurAxis|HSDT: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Passage Bio, Inc. (PASG)|NEUP - Kapitalizatsiyaning foydaga nisbati|Minerva Neurosciences - Narx-foyda koeffitsiyenti|athira.com - Narxning foydaga nisbati|Addex Therapeutics Ltd - P/E multiplikatori|Biznesning o‘zini qoplash muddati Alzamend Neuro, Inc. ALZN|CYCN: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Protagenic Therapeutics, Inc. PTIX|KTTA (Pasithea Therapeutics Corp) - P/E multiplikatori|Cortigent Medical (CRGT) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Avenue Therapeutics, Inc. (ATXI)|Narxning foydaga nisbati BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CHRO|ELYM - Narxning foydaga nisbati|ITCI (Intra-Cellular Therapies) - Narx-foyda multiplikatori|LBPH: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Marinus Pharmaceuticals Inc (MRNS)|Narx-foyda koeffitsiyenti NKGN|P/E multiplikatori NeuroBo Pharma|Narxning foydaga nisbati Sage Therapeutics, Inc. (SAGE)|SNPX (synaptogen.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Trevena TRVN|anewmeds.com (WENA) - Kapitalizatsiyaning foydaga nisbati|CERE - Narxning foydaga nisbati
